As used in ORS 475A.210 to 475A.722:
(1)“Administration session” means a session at which a client consumes and experiences the effects of a psilocybin product under the supervision of a psilocybin service facilitator.
(2)“Client” means an individual that is provided psilocybin services in this state.
(3)“Integration session” means a meeting between a client and a psilocybin service facilitator that may occur after the client completes an administration session.
(4)“Legal entity” means a corporation, limited liability company, limited partnership, or other legal entity that is registered with the office of the Secretary of State or with a comparable office of another jurisdiction.
(5)“Licensee” means a person that holds a license issued under ORS 475A.290, 475A.305, 475A.325 or 475A.5 Free access — add to your briefcase to read the full text and ask questions with AI
As used in ORS 475A.210 to 475A.722:
(1) “Administration session” means a session at which a client consumes and experiences the effects of a psilocybin product under the supervision of a psilocybin service facilitator.
(2) “Client” means an individual that is provided psilocybin services in this state.
(3) “Integration session” means a meeting between a client and a psilocybin service facilitator that may occur after the client completes an administration session.
(4) “Legal entity” means a corporation, limited liability company, limited partnership, or other legal entity that is registered with the office of the Secretary of State or with a comparable office of another jurisdiction.
(5) “Licensee” means a person that holds a license issued under ORS 475A.290, 475A.305, 475A.325 or 475A.594.
(6) “Licensee representative” means an owner, director, officer, manager, employee, agent or other representative of a licensee, to the extent that the person acts in a representative capacity.
(7) “Manufacture” means the manufacture, planting, cultivation, growing, harvesting, production, preparation, propagation, compounding, conversion or processing of a psilocybin product, either directly or indirectly by extraction from substances of natural origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis, and includes any packaging or repackaging of the psilocybin product or labeling or relabeling of its container.
(8)(a) “Premises” includes the following areas of a location licensed under ORS 475A.210 to 475A.722:
(A) All public and private enclosed areas at the location that are used in the business operated at the location, including offices, kitchens, rest rooms and storerooms;
(B) All areas outside a building that the Oregon Health Authority has specifically licensed for the manufacturing of psilocybin products or the operation of a psilocybin service center; and
(C) For a location that the authority has specifically licensed for the operation of a psilocybin service center outside a building, that portion of the location used to operate the psilocybin service center and provide psilocybin services to clients.
(b) “Premises” does not include a primary residence.
(9) “Preparation session” means a meeting between a client and a psilocybin service facilitator that must occur before the client participates in an administration session.
(10) “Psilocybin” means psilocybin or psilocin.
(11) “Psilocybin product manufacturer” means a person that manufactures psilocybin products in this state.
(12)(a) “Psilocybin products” means:
(A) Psilocybin-producing fungi; and
(B) Mixtures or substances containing a detectable amount of psilocybin.
(b) “Psilocybin products” does not include psilocybin services.
(13) “Psilocybin service center” means an establishment:
(a) At which administration sessions are held; and
(b) At which other psilocybin services may be provided.
(14) “Psilocybin service center operator” means a person that operates a psilocybin service center in this state.
(15) “Psilocybin service facilitator” means an individual that facilitates the provision of psilocybin services in this state.
(16) “Psilocybin services” means services provided to a client before, during, and after the client’s consumption of a psilocybin product, including:
(a) A preparation session;
(b) An administration session; and
(c) An integration session.
(17) “Two-year program development period” means the period beginning on January 1, 2021 and ending no later than December 31, 2022.